Yabao Pharmaceutical Group Co Ltd
SSE:600351
Wall Street
Price Targets
Price Targets Summary
Yabao Pharmaceutical Group Co Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Yabao Pharmaceutical Group Co Ltd's stock price target?
Not Available
Yabao Pharmaceutical Group Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Yabao Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
3%
For the last 13 years the compound annual growth rate for Yabao Pharmaceutical Group Co Ltd's revenue is 4%. The projected CAGR for the next 6 years is 3%.
What is Yabao Pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
-4%
For the last 13 years the compound annual growth rate for Yabao Pharmaceutical Group Co Ltd's operating income is 1%. The projected CAGR for the next 10 years is -4%.
What is Yabao Pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
1%
For the last 13 years the compound annual growth rate for Yabao Pharmaceutical Group Co Ltd's net income is 2%. The projected CAGR for the next 6 years is 1%.